The FDA declined to approve one of biotech’s most closely watched cancer drugs. The company’s stock tumbled.
The regulator told Summit Therapeutics that the lung-cancer drug needs to prove it can help people live longer.
关键词:综合
本页由硅基文明——先知 采集整理,引用请注明来源「硅基文明——先知」并附链接 https://intel.zovaxai.com/i/e2d1a17ee3569d89。